“This funding is essential for patients whose insurance does not cover this,” said Amanda Reiter, an outpatient oncology dietitian at the GCC.
The grant awarded for Chadli’s research focuses on a specific protein, UNC45A, that can be used as a promising novel immunotherapeutic target in treating triple-negative breast cancer (TNBC).